✦ LIBER ✦

A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome

✍ Scribed by Hazama, Shoichi; Nakamura, Yusuke; Takenouchi, Hiroko; Suzuki, Nobuaki; Tsunedomi, Ryouichi; Inoue, Yuka; Tokuhisa, Yoshihiro; Iizuka, Norio; Yoshino, Shigefumi; Takeda, Kazuyoshi; Shinozaki, Hirokazu; Kamiya, Akira; Furukawa, Hiroyuki; Oka, Masaaki

Book ID: 125401199
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 402 KB
Volume: 12
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-12-63

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3065 POSTER Safety and efficacy of sunit

3065 POSTER Safety and efficacy of sunitinib and FOLFIRI in combination in treatment-naive metastatic colorectal cancer (mCRC): a phase I study

✍ F. Vazquez; A. Carrato; N. Starling; I. Chau; P. Hill; M.J. Lechuga; J. Tursi; R 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB

A Phase 2b, Double-Blind, Randomized Stu

A Phase 2b, Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared With Placebo (PBO) When Administered in Combination With Chemotherapy (Modified FOLFOX6) for First-line Treatment (tx) of Patients (Pts) With Metastatic Colorectal Cancer (mCRC). The RESPECT Trial

✍ J. Tabernero; R. Garcia-Carbonero; C.H. Könne; P.J. O'Dwyer; A. Sobrero; E. Van 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Possibility of immunotherapy for biliary

Possibility of immunotherapy for biliary tract cancer: how do we prove efficacy? Introduction to a current ongoing phase I and randomized phase II study to evaluate the efficacy and safety of adding Wilms tumor 1 peptide vaccine to gemcitabine and cisplatin for the treatment of advanced biliary tract cancer (WT-BT trial)

✍ Takuji Okusaka, Makoto Ueno, Tosiya Sato, Yuji Heike 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 338 KB